Albion Capital

Established in 1996, Albion Capital is a London-based venture capital firm that has been supporting visionary founders and technologies for nearly three decades. The firm manages approximately £1 billion in assets, focusing on early-stage and growth-stage investments across various sectors, including deeptech, software, healthcare, and infrastructure. Albion Capital is the technology investment arm of Albion Capital Group LLP, which is authorised and regulated by the Financial Conduct Authority.

Albion Capital's investment strategy centers on providing long-term capital and scale-up expertise to UK early-stage software, healthcare, and deeptech companies. The firm typically invests between £3 million and £12 million in companies at various stages, from pre-seed to pre-IPO. Their portfolio includes over 50 companies, with a particular emphasis on sectors such as deeptech, software, healthcare, and infrastructure. Notable investments include Quantexa, a decision intelligence platform, and Oviva, Europe's leading virtual clinic for weight-related diseases.

With a team of 24 professionals led by Managing Partner Will Fraser-Allen, Albion Capital has a strong track record of over 100 successful exits. The firm's deep sector knowledge and operational experience in scaling technology businesses enable them to provide practical guidance on common growth challenges. Albion Capital's unique position in the university ecosystem offers privileged access to high-quality investment opportunities, particularly in the commercialization of university research and spinouts.